A. Bryskier
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 67
- Antibiotics Pharmacokinetics and Efficacy 57
-
- Antibiotic Resistance in Bacteria 49
- Co-authors
- Jean‐François Chantot (4 shared papers)Nalin Rastogi (7 shared papers)Khye Seng Goh (6 shared papers)Ralf René Reinert (5 shared papers)Rudolf Lütticken (5 shared papers)M. T. Labro (9 shared papers)Jacqueline Chevalier (1 shared paper)Renaud Chollet (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (31 papers)Journal of Antimicrobial Chemotherapy (13 papers)Expert Opinion on Investigational Drugs (11 papers)Clinical Microbiology and Infection (8 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
A. Bryskier
108 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 109
- Molecular Medicine 658
- Pharmacology 750
- Infectious Diseases 738
- Applied Microbiology and Biotechnology 61
- Microbiology 196
Countries citing papers authored by A. Bryskier
This map shows the geographic impact of A. Bryskier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bryskier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bryskier more than expected).
Fields of papers citing papers by A. Bryskier
This network shows the impact of papers produced by A. Bryskier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bryskier. The network helps show where A. Bryskier may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Bryskier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial agents: antibacterials and antifungals. | 2005 | 138 |
| 2 | 2000 | 101 | |
| 3 | 1995 | 97 | |
| 4 | 2004 | 94 | |
| 5 | 2003 | 83 | |
| 6 | 2003 | 76 | |
| 7 | 1986 | 62 | |
| 8 | 2000 | 62 | |
| 9 | 1998 | 60 | |
| 10 | 2000 | 58 | |
| 11 | 1998 | 57 | |
| 12 | 1998 | 55 | |
| 13 | 1996 | 52 | |
| 14 | 1984 | 47 | |
| 15 | 1998 | 46 | |
| 16 | 1999 | 46 | |
| 17 | 2000 | 45 | |
| 18 | 1999 | 42 | |
| 19 | 2000 | 39 | |
| 20 | 2002 | 39 |
About A. Bryskier
A. Bryskier is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Infectious Diseases and Molecular Biology, having authored 121 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (57 papers), Antibiotic Resistance in Bacteria (49 papers), Pneumonia and Respiratory Infections (30 papers), Antimicrobial Resistance in Staphylococcus (13 papers), Cancer therapeutics and mechanisms (13 papers), Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). The work is most often cited by research in Molecular Medicine (658 citations), Pharmacology (750 citations), Infectious Diseases (738 citations), Applied Microbiology and Biotechnology (61 citations) and Microbiology (196 citations). A. Bryskier has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Jean‐François Chantot, Nalin Rastogi, Khye Seng Goh, Ralf René Reinert, Rudolf Lütticken, M. T. Labro, Jacqueline Chevalier, Renaud Chollet, Jean‐Marie Pagès and H Drugeon. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Expert Opinion on Investigational Drugs, Clinical Microbiology and Infection and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.